Fresh Tracks Therapeutics, Inc. (FRTX)
USD 0.74
(-0.34%)
USD 0.74
(-0.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.34 Million | -19.33 Million | -36.14 Million | -20.03 Million | -35.98 Million | 3.96 Million |
| Net Income | -5.69 Million | -21.1 Million | -39.47 Million | -20.91 Million | -23.87 Million | -9.23 Million |
| Depreciation & Amortization | 41 Thousand | 30 Thousand | 22 Thousand | 10 Thousand | 28 Thousand | 49 Thousand |
| Deferred income taxes | - | 132.06 Million | -437 Thousand | 25 Thousand | -2.13 Million | -244 Thousand |
| Stock-based compensation | 1.91 Million | 2.15 Million | 2.26 Million | 1.99 Million | 1.53 Million | 711 Thousand |
| Change in working capital | -669 Thousand | -478 Thousand | -556 Thousand | -1.64 Million | -13.63 Million | 12.2 Million |
| Other non-cash items | 60 Thousand | -132 Million | 2.03 Million | 500 Thousand | 2.09 Million | 486 Thousand |
| Investing Cash Flow | - | -47 Thousand | -36 Thousand | 4.47 Million | 32.51 Million | -12 Thousand |
| Investments in PPE | - | -47 Thousand | -36 Thousand | -23 Thousand | -7000.00 | -12 Thousand |
| Acquisitions | - | - | - | - | - | -1.29 Million |
| Investment purchases | - | - | - | - | - | -45 Million |
| Sales/Maturities of investments | - | - | - | 4.5 Million | 19.5 Million | 44.68 Million |
| Other Investing Activities | - | - | - | 4.5 Million | 13.01 Million | 1.61 Million |
| Financing Cash Flow | 6.53 Million | 1.17 Million | 32.95 Million | 38.44 Million | 2.63 Million | -1.28 Million |
| Debt repayment | - | - | - | -437 Thousand | -4.8 Million | -1.28 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 37 Thousand | -51 Thousand | - | - | - |
| Common Stock Issuance | 6.56 Million | 1.19 Million | 24 Million | 37.97 Million | - | 1000.00 |
| Other Financing Activities | -38 Thousand | -55 Thousand | 8.99 Million | 463 Thousand | 7.44 Million | -6000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -165 Thousand | -1.03 Million | 1.02 Million | -1.67 Million | -1.82 Million | 2.84 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -504 Thousand | 556 Thousand | -1.57 Million | 28 Thousand | -11.8 Million | 9.35 Million |
| Cash at beginning of period | 8.68 Million | 26.88 Million | 30.11 Million | 7.23 Million | 8.06 Million | 5.39 Million |
| Cash at end of period | 10.86 Million | 8.68 Million | 26.88 Million | 30.11 Million | 7.23 Million | 8.06 Million |
| Capital Expenditure | - | -47 Thousand | -36 Thousand | -23 Thousand | -7000.00 | -12 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | 1.28 Million |
| Net cash flow / Change in cash | 2.18 Million | -18.2 Million | -3.23 Million | 22.88 Million | -835 Thousand | 2.66 Million |
| Free Cash Flow | -4.34 Million | -19.38 Million | -36.18 Million | -20.05 Million | -35.98 Million | 3.95 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.69 Million | -1.23 Million | 2.1 Million | -2.28 Million | -4.27 Million | -21.1 Million |
| Depreciation & Amortization | 41 Thousand | 10 Thousand | 11 Thousand | 10 Thousand | 10 Thousand | 30 Thousand |
| Deferred income taxes | - | - | - | - | - | 132.06 Million |
| Stock-based compensation | 1.91 Million | 267 Thousand | 863 Thousand | 410 Thousand | 379 Thousand | 2.15 Million |
| Change in working capital | -669 Thousand | -163 Thousand | 87 Thousand | 29 Thousand | -622 Thousand | -478 Thousand |
| Other non-cash items | 60 Thousand | - | 17 Thousand | 19 Thousand | 24 Thousand | -132 Million |
| Investing Cash Flow | - | - | - | - | - | -47 Thousand |
| Investments in PPE | - | - | - | - | - | -47 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 6.53 Million | -28 Thousand | -10 Thousand | - | 6.56 Million | 1.17 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | 37 Thousand |
| Common Stock Issuance | 6.56 Million | - | - | - | 6.56 Million | 1.19 Million |
| Other Financing Activities | -38 Thousand | -28 Thousand | - | - | 6.56 Million | -55 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -165 Thousand | -203 Thousand | 353 Thousand | -379 Thousand | 64 Thousand | -1.03 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -504 Thousand | 40 Thousand | -266 Thousand | 408 Thousand | -64 Thousand | 556 Thousand |
| Cash at beginning of period | 8.68 Million | 12.02 Million | 8.94 Million | 10.76 Million | 8.68 Million | 26.88 Million |
| Cash at end of period | 10.86 Million | 10.86 Million | 12.02 Million | 8.94 Million | 10.76 Million | 8.68 Million |
| Capital Expenditure | - | - | - | - | - | -47 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.18 Million | -1.15 Million | 3.07 Million | -1.81 Million | 2.08 Million | -18.2 Million |
| Free Cash Flow | -4.34 Million | -1.12 Million | 3.08 Million | -1.81 Million | -4.48 Million | -19.38 Million |
ZH
HMY
FXCNF
TUWOY
603982
BIJ